Introduction: Rhizoctonia solani causes major damage to potato crops. An ecological option to combat the effects of this phytopathogenic agent consists of treating the seeds (tubers) with microbial bioproducts based on Bacillus sp., previously isolated from the rhizosphere of Solanum tuberosum [1,2,3,4,5].
Materials and methods: the tests were carried out in vitro on Rhizoctonia solani and in vivo on a Solanum tuberosum culture with bioproducts based on Bacillus sp., which contained 105 CFU.
Results and discussion: the tests carried out in vitro on Rhizoctonia solani with bioproducts based on Bacillus sp. showed that these bioproducts have the ability to inhibit the growth of this phytopathogen by about 80%. The tests carried out in vivo on two varieties of Solanum tuberosum, in which the microbial bioproducts were applied to the seeds (tubers), revealed that the presence of the studied bioproducts increased the potato plant resistance to this phytopathogen. The incidence of disease caused by this phytopathogen was reduced to about 20% in the treated potato plants compared to the untreated culture, where the incidence of disease can reach 87%. Another advantage of applying bioproducts based on Bacillus sp. is increasing the tuber production yield up to 40% compared to the untreated variants.
Conclusions: the obtaining and large-scale use of bioproducts based on Bacillus sp. in potato cultures represent an ecological and advantageous option due to their biocontrol and plant growth-promoting properties [6,7].
Author Contributions
Conceptualization: N.R. and R.Z.; writing—original draft preparation, N.R., M.C. and M.D.; writing—review and editing, R.Z. and N.R.; visualization, R.Z.; supervision, N.R. and R.Z.; project administration, N.R. and C.M. All authors have read and agreed to the published version of the manuscript.
Funding
This work was carried out through the PN 23.06 Core Program—ChemNewDeal within the National Plan for Research, Development and Innovation 2022–2027, developed with the support of the Ministry of Research, Innovation, and Digitization, project no. PN 23.06.01.01 (AQUAMAT). Also, this research was funded by ADER project no 5.1.6/17.07.2023.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data are contained within this work.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Bandow, J.E.; Brötz, H.; Hecker, M. Bacillus subtilis tolerance of moderate concentrations of rifampin involves the b-dependent general and multiple stress response. J. Bacteriol. 2002, 184, 459–467. [Google Scholar] [CrossRef] [PubMed]
- Berkeley, R.C.W.; Logan, N.A.; Shute, L.A.; Capey, A.G. Identification of bacillus species. Methods Microbiol. 1984, 16, 291–328. [Google Scholar]
- Radu, N.; Chirvase, A.A.; Zambila, N. Ecological products for agriculture. Sci. Bull. Ser. F Biotechnol. 2012, XVI, 56–62. [Google Scholar]
- Radu, N.; Meghea, A. Studies concerning the use of microbial biomass by fertilizers manufacture. J. Environ. Prot. Ecol. 2007, 8, 824–834. [Google Scholar]
- Radu, N.; Chirvase, A.A.; Babeanu, N.; Popa, O.; Cornea, P.; Pirvu, L.; Bostan, M.; Ciric, A.; Mathe, E.; Radu, E.; et al. Study regarding the potential use of a spent microbial biomass in fertilizer manufacturing. Agronomy 2020, 10, 299. [Google Scholar] [CrossRef]
- Zaharie, M.G.O.; Radu, N.; Pirvu, L.; Bostan, M.; Voicescu, M.; Begea, M.; Constantin, M.; Voaides, C.; Babeanu, N.; Roman, V. Studies Regarding the Pharmaceutical Potential of Derivative Products from Plantain. Plants 2022, 11, 1827. [Google Scholar] [CrossRef] [PubMed]
- Radu, N.; Chirvase, A.A.; Babeanu, N.; Begea, M. Entrepreneurship in the field of life sciences: The personal skills needed to start an innovative SME. Sci. Pap. Ser. Manag. Econ. Eng. Agric. Rural Dev. 2021, 19, 376–380. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).